Practice Contact Information
Montefiore Medical Center/Albert Einstein College of Medicine
3400 Bainbridge Avenue
3rd Floor Medical Arts Pavilion
Bronx
New York
10467
United States
Phone: 718-920-4646
Email:
Web Site:
Areas of surgical specialization in Head and Neck Surgery
Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon
Biography/Statement
Dr. Thomas Ow is a head and neck surgeon at Montefiore Medical Center. He has expertise in the surgical treatment of all head and neck tumors, including mouth and throat cancers, sinus cancers, cancers of the voice box, salivary glands, thyroid and parathyroid glands, and skin cancers in the head and neck regions. Dr. Ow is also a translational researcher, studying how head and neck cancers grow and spread, and developing biomarkers and new treatments so patients can have better outcomes.
Clinical Trials
Bibliography
Full citation list can be found at:
https://pubmed.ncbi.nlm.nih.gov/?term=Ow%20TJ&sort=date&pos=8
Ow TJ, Spector-Bagdady K, Cowan E, Shuman AG. Broad Consent for Head and Neck Cancer Research. Otolaryngol Head Neck Surg. 2018 May;158(5):835-838. PMID: 29529925.
Tharakan T, Jiang S, Fastenberg J, Ow TJ, Schiff B, Smith RV, Mehta V. Postoperative Pain Control and Opioid Usage Patterns among Patients Undergoing Thyroidectomy and Parathyroidectomy. Otolaryngol Head Neck Surg. 2019 Mar;160(3):394-401. PMID: 30324865
Fattouh M, Chang GY, Ow TJ, Shifteh K, Rosenblatt G, Patel VM, Smith RV, Prystowsky MB, Schlecht NF. Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer. Head Neck. 2019 Mar;41(3):707-714. PMID: 30582237
Mehta V, Ow TJ, Kim S, Tharakan T, Schiff B, Smith RV, In H. Significant racial differences in the incidence and behavior of the follicular variant of papillary thyroid carcinoma. Head Neck. 2019 May;41(5):1403-1411. PMID: 30652370
Ow TJ, Fulcher CD, Thomas C, Broin PÓ, López A, Reyna DE, Smith RV, Sarta C, Prystowsky MB, Schlecht NF, Schiff BA, Rosenblatt G, Belbin TJ, Harris TM, Childs GC, Kawachi N, Guha C, Gavathiotis E. Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1. Oncotarget. 2019 Jan 11;10(4):494-510. PMID: 30728900; PMCID: PMC6355180.
Bresler A, Mehta V, Schiff BA, Smith RV, Khader S, Ramos-Rivera G, Lin J, Libutti SK, Laird AM, Ow TJ. Comparison of Bethesda cytopathology classification to surgical pathology across racial-ethnic groups. Head Neck. 2019 Jul;41(7):2340-2345. PMID: 30793405
Tharakan T, Jiang S, Fastenberg J, Ow TJ, Schiff B, Smith RV, Mehta V. Response to Confounding Factors on the Prediction of Opioid Usage after Thyroidectomy and Parathyroidectomy Surgery. Otolaryngol Head Neck Surg. 2019 Aug;161(2):371-372. PMID: 31369346
Liao DZ, Schlecht NF, Rosenblatt G, Kinkhabwala CM, Leonard JA, Ference RS, Prystowsky MB, Ow TJ, Schiff BA, Smith RV, Mehta V. Association of Delayed Time to Treatment Initiation With Overall Survival and Recurrence Among Patients With Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population. JAMA Otolaryngol Head Neck Surg. 2019 Sep 12. PMID: 31513264
Hochfelder CG, McGinn AP, Mehta V, Castellucci E, Kabarriti R, Ow TJ. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study. Laryngoscope. 2019 Dec 10. PMID: 31821572
Ow TJ, Thomas C, Fulcher CD, Chen J, López A, Reyna DE, Prystowsky MB, Smith RV, Schiff BA, Rosenblatt G, Belbin TJ, Harris TM, Childs GC, Kawachi N, Schlecht NF, Gavathiotis E. Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma. Laryngoscope. 2020 Jan 2. doi: 10.1002/lary.28441. PMID: 31894587
Alli BY, Burk RD, Fatahzadeh M, Grossberg RM, Smith RV, Ow TJ, Wiltz M, Polanco J, Rousseau MC, Nicolau B, Schlecht NF. HIV modifies the effect of tobacco smoking on oral human papillomavirus infection. J Infect Dis. 2020 Mar 25. PMID: 32211783
Shaverdashvili K, Azimi-Neko E, Cohen P, Akbar N, Ow TJ, Halmos B, Castellucci E. INI-1 (SMARCB1) deficient undifferentiated sinonasal carcinoma: novel paradigm of molecular testing in the diagnosis and management of sinonasal malignancies [published online ahead of print, 2020 Apr 26]. Oncologist. 2020;10.1634/theoncologist.2019-0830. doi:10.1634/theoncologist.2019-0830. PMID: 32337786